Results 131 to 140 of about 1,214,228 (245)

GHRHR Deficiency Enhances Retinal Ganglion Cell Survival and Visual Functions in Experimental Glaucoma by Inhibiting Ferroptosis

open access: yesAdvanced Science, EarlyView.
Glaucoma, a major cause of blindness, involves retinal ganglion cell (RGC) degeneration. This study shows growth hormone‐releasing hormone receptor (GHRHR) deficiency preserves RGC survival and restores vision, unlike activation which only aids survival.
Yan Tong   +24 more
wiley   +1 more source

ROS Self‐Supply Nanoplatform Based on Fenton Catalyst for Chemodynamic and Immunotherapy: Reprogramming Cold Tumor Into Hot Tumor in Cancer Treatment

open access: yesAdvanced Science, EarlyView.
A multifunctional HA‐conjugated nanoplatform (HA‐PGMC) integrates CuO2, glucose oxidase, and mil‐100 to enable cascade catalytic ROS generation in tumor microenvironments. This self‐supplying ROS strategy induces immunogenic cell death, reprograms “cold” tumors into “hot” ones, and synergizes with PD‐L1 blockade, achieving potent chemodynamic ...
Man Lung Lee   +6 more
wiley   +1 more source

Influence of immunomodulatory drugs on the gut microbiota. [PDF]

open access: yesTransl Res, 2021
Cohen I, Ruff WE, Longbrake EE.
europepmc   +1 more source

Reports of side effects associated with the use of drugs 1977

open access: yes, 1977
The National Drugs Advisory Board received 525 Reports in all during 1977. From these 879 Side-Effects were recorded with the use of drugs during the year. There were 18 cases of Drug Interactions- these are listed separately.
National Drugs Advisory Board (NDAB)
core  

Thalidomide and immunomodulatory drugs in the treatment of cancer

open access: yes, 2005
Thalidomide has antiangiogenic and immunomodulatory properties and has recently been used in the management of human malignancies. Multiple studies have confirmed its activity in multiple myeloma, alone or combined with dexamethasone and/or chemotherapy ...
Bamias, A   +3 more
core   +1 more source

Lactiplantibacillus Plantarum GUANKE Alleviates Allergic Asthma by Restricting Monocyte‐to‐DC Differentiation Via Microbiota‐Associated IAA

open access: yesAdvanced Science, EarlyView.
Lactiplantibacillus plantarum GUANKE remodels the indigenous gut microbiota and is associated with microbiota‐dependent restoration of circulating IAA. IAA treatment attenuates JAK3‐STAT3 and Jag1‐Notch4‐Hey1 signaling and reduces CX3CR1+Ly6C− monocytic precursor generation and pulmonary CD11b+ DC accumulation, together with reduced Th2 inflammation ...
Yujia He   +10 more
wiley   +1 more source

The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy. [PDF]

open access: yesFront Pharmacol, 2022
Wiesinger AM   +7 more
europepmc   +1 more source

National Drugs Advisory Board. Consolidated annual reports 1991-1994

open access: yes, 1994
The past four years have seen events with considerable implications for the Board. The volume of work has continued to grow in the established areas of authorisation and monitoring of human and veterinary medicines, licensing and monitoring of ...
National Drugs Advisory Board (NDAB)
core  

Smart Nanotechnologies for Multimodal Neuromodulation and Brain Interfacing

open access: yesAdvanced Science, EarlyView.
Recent advances in smart nanotechnologies are expanding the toolbox for brain interfacing, from wireless neuromodulation and high‐resolution sensing to targeted delivery within the central nervous system. By combining responsive nanomaterials with bioinspired design, these platforms enable multimodal interactions with neurons and glia, while also ...
Tommaso Curiale   +6 more
wiley   +1 more source

COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization. [PDF]

open access: yesRheumatol Ther, 2023
Azizi H   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy